Back HCV Epidemiology

HCV Epidemiology & Mortality

AASLD 2011: HCV Screening of 1945-1965 Birth Cohort Appears Cost-Effective

Screening all people in the U.S. in the 46 to 66 year age group for hepatitis C virus (HCV) infection would identify more than 800,000 additional cases, and offering testing plus treatment if needed would be cost-effective, according to an analysis presented at the American Association for the Study of Liver Diseases Liver Meeting (AASLD 2011) this month in San Francisco.alt

Read more:

AASLD 2011: Deaths Due to Hepatitis C Now Exceed HIV Deaths

Deaths related to hepatitis C virus (HCV) and its complications have exceeded deaths due to HIV/AIDS since 2007, according to an analysis by Centers for Disease Control and Prevention (CDC) researchers presented at the American Association for the Study of Liver Diseases Liver Meeting (AASLD 2011) last week in San Francisco.alt

Read more:

Undercounted Populations Raise Estimate of True U.S. Hepatitis C Prevalence

The number of people living with hepatitis C virus (HCV) infection in the U.S. is probably greater than the usual estimate due to undercounting of high-risk populations in household surveys, including prisoners, homeless people, and injection drug users, researchers reported in the September 2011 issue of Liver International.alt

Read more:

High Rate of HCV Infection Shows Young Drug Injectors Need Better Prevention Interventions

Young infection drug users (IDUs) continue to become infected with hepatitis C at an alarming rate, underscoring the need for new and better prevention efforts, according to a study described in the October 28, 2011, issue of the CDC's Morbidity and Mortality Weekly Report.alt

Read more:

Is Hepatitis C Rising among Young People?

Massachusetts surveillance data showed an increase in hepatitis C among adolescents and young adults during 2002-2009, thought to be largely attributable to injection drug use.

Read more: